An Information Tool Incorporating Real-World Outcome Data for Women With Metastatic Breast Cancer Eligible for Treatment With a CDK4/6 Inhibitor: Development and Evaluation

Ellen G Engelhardt   ^{1 *} , PhD ;   Mariska Q N Hackert   ^{1 *} , PhD ;   Anne Vogelaar   ¹ , MSc ;   Afke F de Jong   ² , MSc, MD ;   Cristina Guerrero Paez   ³ , MSc ;   Annette W G van der Velden   ⁴ , MD ;   Christa Putker   ⁵ , MSc ;   Mariette J Agterof   ⁵ , MD, PhD ;   Ewoudt M W van de Garde   ^{6, 7} , MD, PhD ;   Cornelia F van Uden-Kraan   ¹ , PhD

¹ Santeon (Netherlands), Utrecht, The Netherlands

² Stichting Kijksluiter, Amsterdam, The Netherlands

³ Borstkankervereniging Nederland, Utrecht, The Netherlands

⁴ Department of Internal Medicine, Martini Ziekenhuis, Groningen, The Netherlands

⁵ Department of Internal Medicine, St. Antonius Hospital, Utrecht/Nieuwegein, The Netherlands

⁶ Department of Pharmacy, St. Antonius Hospital, Utrecht/Nieuwegein, The Netherlands

⁷ Department of Pharmaceutical Sciences, Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht University, Utrecht, The Netherlands

*these authors contributed equally